Ailezhen Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Ailezhen Bio General Information
Description
Manufacturer of biopharmaceutical formulations and medical-grade biochemical products intended for clinical research and therapeutic applications. The company focuses on the development and production of biologics, chemical agents, and medical devices, enabling pharmaceutical firms and healthcare institutions to access specialized compounds, experimental treatments, and precision packaging solutions through integrated R&D pipelines, regulatory-compliant manufacturing, and targeted distribution channels that support innovation in drug development and patient care.
Contact Information
Corporate Office
- Unit E283, North Tower, Building A1
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215000
- China
Corporate Office
- Unit E283, North Tower, Building A1
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215000
- China
Ailezhen Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 18-Jan-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 31-Oct-2018 | Completed | Startup |
Ailezhen Bio FAQs
-
When was Ailezhen Bio founded?
Ailezhen Bio was founded in 2018.
-
Where is Ailezhen Bio headquartered?
Ailezhen Bio is headquartered in Suzhou, China.
-
What industry is Ailezhen Bio in?
Ailezhen Bio’s primary industry is Therapeutic Devices.
-
Is Ailezhen Bio a private or public company?
Ailezhen Bio is a Private company.
-
What is Ailezhen Bio’s current revenue?
The current revenue for Ailezhen Bio is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process